How Credentialing Impacts Your Cash Flow?

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

When you start a new practice or hire a new physician for your practice, most people think hiring or paying them is the biggest issue. However, that’s not true. In reality, the main issue in the revenue cycle management is the gap between hiring a new provider and receiving payment for their services. This issue […]

The post How Credentialing Impacts Your Cash Flow? appeared first on Medical News Bulletin.

Is Homeopathy Right for You? Insights from Sydney Practitioners

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

In today’s healthcare setting, patients are increasingly looking towards complementary and alternative modes of treatment in addition to the conventional modes of treatment.  Homeopathy is one such mode of treatment that has gained popularity because of the personalized modes of treatment and non-invasive methods.  However, the question of whether it is the right choice for […]

The post Is Homeopathy Right for You? Insights from Sydney Practitioners appeared first on Medical News Bulletin.

How Registered Dietitians Help with Disordered Eating

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

A person sits at a kitchen table staring at a bowl of oatmeal. They calculate every gram of fiber and carbohydrate in their head. This intense focus on numbers often signals a deep struggle with food. These situations require help from a professional who understands food and the body. Many people recognize the need for […]

The post How Registered Dietitians Help with Disordered Eating appeared first on Medical News Bulletin.

Five Benefits of Early Orthodontic Intervention

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Children start losing their baby teeth around age six. This stage marks a big change for their jaw and face. Permanent teeth need more room because they are bigger than baby teeth. Many parents see crowded teeth and feel worried about the future. They often think they should wait for all adult teeth to grow […]

The post Five Benefits of Early Orthodontic Intervention appeared first on Medical News Bulletin.

How AI Clinical Tools Are Supporting Healthcare Provider Mental Health

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Ask a therapist what they dread most about their job. Nine times out of ten, it’s not the difficult clients. It’s the paperwork. That stack of clinical notes waiting after the last session ends, bleeding into evenings and weekends and the occasional holiday morning spent hunched over a laptop. The documentation burden in healthcare isn’t […]

The post How AI Clinical Tools Are Supporting Healthcare Provider Mental Health appeared first on Medical News Bulletin.

FDA approves new form of PET imaging agent for prostate cancer

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release.
As Healio previously reported, the FDA approved piflufolastat F 18 injection (Pylarify, Lantheus Holdings) in May 2021 to identify suspected metastasis or recurrence of prostate cancer. On March 6, Lantheus Holdings announced the approval of a new formulation (Pylarify TruVu).
The agent is indicated for PET imaging of prostate-specific membrane antigen positive lesions in men with prostate cancer with suspected metastasis who

Multiple studies show benefit of NCX 470 in glaucoma

Three studies presented at the American Glaucoma Society meeting demonstrated the potential benefit of NCX 470 in patients with glaucoma.
NCX 470 (Nicox) is a nitric oxide-donating bimatoprost eye drop designed to lower IOP in patients with glaucoma. Sanjay G. Asrani, MD, presented data from the phase 3 DENALI trial that compared NCX 470 with latanoprost 0.005% in 696 patients with glaucoma or ocular hypertension.
As Healio previously reported, NCX 470 achieved noninferiority in lowering IOP compared with latanoprost. Asrani said in his presentation that NCX 470 demonstrated greater IOP

Teclistamab-daratumumab snag FDA approval in multiple myeloma

The FDA has approved teclistamab-cqyv in combination with daratumumab hyaluronidase-fihj for adults with relapsed or refractory multiple myeloma who received at least one prior line of therapy.
As the third approval under the Commissioner’s National Priority Voucher pilot program, teclistamab-cqyv (Tecvayli, Johnson & Johnson) plus daratumumab hyaluronidase-fihj (Darzalex Faspro, Johnson & Johnson) is now cleared for patients with relapsed or refractory multiple myeloma who previously received either a proteasome inhibitor or an immunomodulatory agent.
This approval also upgrades

Several healthy diets lower the risk for cognitive decline

Multiple healthy diets, especially the Dietary Approaches to Stop Hypertension-style diet, were tied to better cognitive function and a lower risk for cognitive decline, a study in JAMA Neurology indicated.
Prior studies have suggested that some healthy diets may have protective effects against cognitive impairment while raising the odds of healthy aging.
But the role of diet in cognitive health “is still uncertain,” Hui Chen, PhD, from the department of nutrition at Harvard T.H. Chan School of Public Health, and colleagues wrote.
“Discrepancies in existing studies may arise from differences in

GLP-1s may reduce glaucoma risk, studies find

In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus.
“GLP-1 RAs exert both protective and adverse effects on the eye,” Jacky Xiao Feng Huang, a medical student at California Health Sciences University College of Osteopathic Medicine, and colleagues wrote. “On the protective side, GLP-1 RAs improve retinal vascular regulation and help reduce inflammatory signaling in retinal tissues by preserving the blood-retinal barrier and lowering vascular permeability. ... Conversely, adverse